Skip to main navigation Skip to search Skip to main content

Thyrotropin releasing hormone and corticosteroids prior to preterm labour: A survey of current practice in nine European countries

  • Zarko Alfirevic*
  • , Diana Elbourne
  • , A. Truesdale
  • , J. Neilson
  • , J. Rigo
  • , H. Thomson
  • , G. Greisen
  • , N. J. Secher
  • , O. Claris
  • , J. Lepercq
  • , H. Dellagrammaticas
  • , S. Mesogitis
  • , K. Boer
  • , J. H. Kok
  • , L. Januario
  • , A. B. Couceiro
  • , T. Matthews
  • , W. Prendiville
  • , C. Brotons
  • , C. Foradada
  • R. Cooke
*Corresponding author for this work
1 Citation (Scopus)

Abstract

There is considerable variation in the use of cortisosteroids within Europe before possible preterm delivery. Thyrotropin releasing hormone is rarely used as synergistic treatment in most, but not all, European countries-presumably reflecting uncertainty about the effectiveness and safety of this agent.

Original languageEnglish
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume68
Issue number1-2
Pages (from-to)43-45
Number of pages3
ISSN0301-2115
DOIs
Publication statusPublished - Sept 1996

Keywords

  • Corticosteroids
  • Preterm delivery
  • Thyrotropin releasing hormone

Fingerprint

Dive into the research topics of 'Thyrotropin releasing hormone and corticosteroids prior to preterm labour: A survey of current practice in nine European countries'. Together they form a unique fingerprint.

Cite this